StockData
Rani Therapeutics Holdings, Inc. logo

Rani Therapeutics Holdings, Inc. (RANI) stock

RANINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 3/3039% above fair value
$0.56+0.02 (+3.54%)

Close on Nov 17, 2026Market cap $77.98MP/E –Yield –

Rani Therapeutics cash

Cash and short-term investments held at the end of each period.

Rani Therapeutics's cash was $4.87M at Jun 30, 2026. For fiscal 2025 it was $18.62M, up 336.8% from the year before. The highest annual figure on record is $126.01M in fiscal 2022.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$18.62M+336.8%
FY2024Dec 31, 2024$4.26M-33.0%
FY2023Dec 31, 2023$6.36M-94.9%
FY2022Dec 31, 2022$126.01M+7.3%
FY2021Dec 31, 2021$117.45M+60.8%
FY2020Dec 31, 2020$73.06M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$4.87M-52.3%
Q1 FY2026Mar 31, 2026$9.64M-4.6%
Q4 FY2025Dec 31, 2025$18.62M+336.8%
Q3 FY2025Sep 30, 2025$4.14M-3.1%
Q2 FY2025Jun 30, 2025$10.22M+126.3%
Q1 FY2025Mar 31, 2025$10.11M+47.0%
Q4 FY2024Dec 31, 2024$4.26M-33.0%
Q3 FY2024Sep 30, 2024$4.28M-14.0%
Q2 FY2024Jun 30, 2024$4.51M-40.2%
Q1 FY2024Mar 31, 2024$6.88M-63.8%
Q4 FY2023Dec 31, 2023$6.36M-94.9%
Q3 FY2023Sep 30, 2023$4.97M-81.7%
Q2 FY2023Jun 30, 2023$7.55M-92.2%
Q1 FY2023Mar 31, 2023$18.98M-82.4%
Q4 FY2022Dec 31, 2022$126.01M+7.3%
Q3 FY2022Sep 30, 2022$27.22M-79.0%
Q2 FY2022Jun 30, 2022$97.18M+40.2%
Q1 FY2022Mar 31, 2022$107.84M+47.6%
Q4 FY2021Dec 31, 2021$117.45M–
Q3 FY2021Sep 30, 2021$129.74M–
Q2 FY2021Jun 30, 2021$69.31M–
Q4 FY2020Dec 31, 2020$73.06M–

More Rani Therapeutics figures

See a number that looks wrong?